She received betamethasone prior to delivery.
She was also treated with antibiotics prior to delivery.
The infant was delivered by cesarean section.
She emerged with a nuchal cord, was given positive pressure ventilation, intubated in the delivery room.
Spine midline but no dimples.
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  RESPIRATORY:  [**Known lastname 18488**] was intubated in the delivery room for management of respiratory distress syndrome.
On admission to the newborn intensive care unit, the infant received a total of 3 doses of surfactant therapy for management of respiratory distress syndrome.
The infant remained ventilated for a total of 38 days on a combination of conventional ventilation and high frequency ventilation.
Her maximum respiratory support included high frequency ventilation with a mean airway pressure of 16 and amplitude of 26.
She remained on CPAP for a total of 21 days at which time she transitioned to nasal cannula oxygen.
She currently is stable on nasal cannula oxygen flow between 13 to 25 ml per minute and is otherwise stable.
[**Known lastname 18488**] was treated with caffeine citrate until [**2196-7-11**] for management of apnea bradycardia of prematurity.
CARDIOVASCULAR: [**Known lastname 18488**] is status post two courses of indomethacin therapy for patent ductus arteriosus.
Following completion of her second course of indomethacin an echocardiogram documented a patent ductus arteriosus.
A PDA ligation was completed on [**2196-4-29**] and the infant has been cardiovascularly stable until [**2196-7-8**] with the onset of an increasing blood pressure.
She was started on her Captopril on [**2196-7-13**] with little effect.
She was receiving intermittent hydralazine for immediate management of hypertension.
On [**7-23**], the infant continued to received hydralazine around the clock in addition to her Captopril dosing.
She was started on her Lasix therapy on [**2196-7-23**] at 2 mg per kg per day.
At the same time she was receiving Captopril at 0.2 mg per kg per day and hydralazine 0.5 mg per kg per dose.
Her last dose of hydralazine was on [**2196-7-25**].
Her Lasix was discontinued on [**2196-7-28**].
She is currently receiving Captopril 0.32 mg PO t.i.d which is 0.1 mg per kg t.i.d.
The infant has central percutaneous intravenous catheter placed on day of life 1 which was maintained throughout the remainder of her IV therapy needs.
Enteral feedings were started on [**2196-5-2**].
Her maximum enteral intake was 130 cc per kg per day of premature Enfamil 30 calorie with ProMod.
She is currently receiving a 140 cc per kg per day of special care 24 calorie, working PO skills, demonstrating good weight gain.
She was treated with phototherapy.
She is currently receiving ferrous sulfate supplementation of 0.35 mg PO once daily.
Blood cultures remained negative at 48 hours at which time ampicillin and gentamicin were discontinued.
During her hospital course she also received 48 hour rule out of vancomycin and gentamycin secondary to increased concerns of itis.
She was also treated with erythromycin ophthalmic ointment secondary to gram positive cocci culture from her eye.
NEUROLOGICAL: She has had several head ultrasounds which were within normal limits, most recent being on [**2196-7-6**].
Feeds at discharge: Continue 140 cc per kg per day of     special care 24 calorie, working NPO enteral feeding.
Medications: Captopril 0.32 mg t.i.d, (0.1 mg per kg     t.i.d).
Ferrous sulfate 0.35 kg PO once daily.
Immunizations received: [**Known lastname 18488**] received Hepatitis B     vaccine on [**2196-5-26**].
She received Pediarix on [**6-26**], [**2196**].
